GCB Masthead
Research at the GCB

This section of the site provides a general description of the currently conducted programs and projects under each one of the five research areas covered by the GCB. The projects are outlined in lay terms for the benefit of potential participants, and include links with recruitment information. Most research activities are multidisciplinary in nature and include several inter-related projects, which enhance the value and application of our studies. Each of the GCB's research areas includes information on the researchers involved, GCBs publications, additional Internet resources and suggested reading for each disorder.

Major Disorders Investigated

Fragile X Syndrome Research
Rett Syndrome Research
Down Syndrome Research
X-Linked Mental Retardation Research
Smith-Lemli-Opitz-Syndrome Research

Other Areas of Interest

Autism Metabolic Research

Participate in Research

A randomized, parallel group, double-blind, placebo-controlled, 12-week, safety and exploratory efficacy and pharmacokinetic, study of RO4917523 in children with Fragile X Syndrome
This research study is being conducted by centers across the United States to help determine if an investigational drug is a safe and effective treatment for symptoms associated with fragile X syndrome. Looking for children with fragile X syndrome, ages 5 through 13 years, to participate in this study.

A randomized, double-blind, 12-week, parallel-group, placebo-controlled, study of the efficacy and safety of RO4917523 in patients with Fragile X Syndrome
This research study is being conducted by centers across the world to help determine if an investigational drug is an effective and safe treatment for symptoms associated with fragile X syndrome. Looking for adolescents and adults with fragile X syndrome, ages 16 through 50 years, to participate in this study.

Creating a Pediatric Imaging-Genomics Data Resource
Children and Young Adults, Ages 3 to 20, Needed for a Study on Brain Development

Investigational Drug Study for Adolescents and Adults with Fragile X Syndrome
Adolescents and adults, ages 12 through 25 years. Study for Treatment of Social Withdrawal Symptoms